A Phase IIb Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) Versus Placebo in Combination With Background Methotrexate in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone

Gómez-Reino Carnota, Juan Jesús
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/4707
PMID: 22006202
ISSN: 0004-3591
Full record
Services
Services
RISMendeleyLinksolver
Date issued
2012
Journal title
ARTHRITIS AND RHEUMATISM
Type of content
Artigo